177 related articles for article (PubMed ID: 21617236)
21. Clinical and biological characteristics of breast cancer.
Kocic B; Filipovic S; Petrovic B; Mijalkovic D; Rancic N; Poultsidi A
J BUON; 2010; 15(4):660-7. PubMed ID: 21229626
[TBL] [Abstract][Full Text] [Related]
22. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
23. Lymphatic vessel density as a predictor of lymph node metastasis and its relationship with prognosis in urothelial carcinoma of the bladder.
Zhou M; He L; Zu X; Zhang H; Zeng H; Qi L
BJU Int; 2011 Jun; 107(12):1930-5. PubMed ID: 20883486
[TBL] [Abstract][Full Text] [Related]
24. [Relationship of vascular endothelial growth factor-C and lymphangiogenesis with the development and prognosis of colon cancer].
Jiang JB; Li XM; Zhang WD; Zhu M; Shou NH
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):516-9. PubMed ID: 16299655
[TBL] [Abstract][Full Text] [Related]
25. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
[TBL] [Abstract][Full Text] [Related]
26. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
27. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
[TBL] [Abstract][Full Text] [Related]
28. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
[TBL] [Abstract][Full Text] [Related]
29. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
30. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
Eroğlu A; Ersöz C; Karasoy D; Sak S
Adv Clin Exp Med; 2017; 26(2):245-249. PubMed ID: 28791841
[TBL] [Abstract][Full Text] [Related]
32. An immunohistochemical analysis of angiogenesis in invasive breast cancer with correlations to clinicopathologic predictors.
Nakopoulou L; Lekkas N; Lazaris AC; Athanassiadou P; Giannopoulou I; Mavrommatis J; Davaris P
Anticancer Res; 1999; 19(5C):4547-53. PubMed ID: 10650809
[TBL] [Abstract][Full Text] [Related]
33. [Relationship between lymph node metastasis and pathologic features of invasive micropapillary carcinoma of breast].
Guo XJ; Chen L; Lang RG; Fan Y; Fu L
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):8-12. PubMed ID: 16608641
[TBL] [Abstract][Full Text] [Related]
34. Microinvasive (T1mic) lobular carcinoma of the breast: clinicopathologic profile of 16 cases.
Ross DS; Hoda SA
Am J Surg Pathol; 2011 May; 35(5):750-6. PubMed ID: 21415700
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
[TBL] [Abstract][Full Text] [Related]
36. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of E-cadherin, Ki-67 and lymphatic vessel invasion in abdominal metastases of human breast cancer.
Debald M; Kaiser C; Abramian A; Schildhaus HU; Locher P; Wolfgarten M; Kuhn W; Braun M
Anticancer Res; 2013 May; 33(5):1971-5. PubMed ID: 23645745
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.
Demir H; Turna H; Can G; Ilvan S
J BUON; 2010; 15(4):774-82. PubMed ID: 21229645
[TBL] [Abstract][Full Text] [Related]
39. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
40. Lymphatic vessel assessment by podoplanin (D2-40) immunohistochemistry in breast cancer.
Wahal SP; Goel MM; Mehrotra R
J Cancer Res Ther; 2015; 11(4):798-804. PubMed ID: 26881521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]